Search

Your search keyword '"Strazzabosco, M."' showing total 1,295 results

Search Constraints

Start Over You searched for: Author "Strazzabosco, M." Remove constraint Author: "Strazzabosco, M."
1,295 results on '"Strazzabosco, M."'

Search Results

51. The optimal timing of hepatitis C therapy in liver transplant-eligible patients: Cost-effectiveness analysis of new opportunities

52. Corrigendum to “Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV” [J Hepatol 68 (2018) 33–41](S0168827817322596)(10.1016/j.jhep.2017.08.019)

53. Impatto dei farmaci anti virali ad azione diretta sulla cura dei pazienti con epatite C: un approccio di value-based medicine

54. Cholangiocyte Biology and Pathobiology

55. Continuous Subcutaneous Insulin Infusion in Italy: Third National Survey

56. Cholangiocarcinoma 2020: the next horizon in mechanisms and management

57. Health related quality of life in chronic liver diseases

58. Cholangiocarcinoma 2020: the next horizon in mechanisms and management

60. Side-chain modification as critical determinant of the therapeutic properties of 24-norursodeoxycholic acid in Mdr2 (Abcb4) knockout mice

61. Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV

63. PC.01.6 MODELING OF PRIMARY SCLEROSING CHOLANGITIS USING BILIARY SPHEROIDS DERIVED FROM BILE FLUID AND NEEDLE-LIVER BIOPSY SAMPLE

64. β-catenin and IL-1β dependent CXCL10 production drives progression of disease in a mouse model of Congenital Hepatic Fibrosis

65. Impatto dei farmaci anti virali ad azione diretta sulla cura dei pazienti con epatite C: un approccio di value-based medicine

66. Corrigendum to 'Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV' [J Hepatol 68 (2018) 33–41](S0168827817322596)(10.1016/j.jhep.2017.08.019)

67. Association of kidney disease measures with risk of renal function worsening in patients with type 1 diabetes 11 Medical and Health Sciences 1103 Clinical Sciences

68. Applicazione della value-based medicine nella valutazione della cura dei pazienti affetti da epatite

69. Impact of multidisciplinary team approach to liver tumors in a tertiary center: 5-years experience

76. Animal models for cystic fibrosis liver disease (CFLD)

77. Diagnostic Value of Quantitative Perfusion Computed Tomography Technique in the Assessment of Tumor Response to Sorafenib in Patients with Advanced Hepatocellular Carcinoma

84. PITER collaborating group. Forecasting Hepatitis C liver disease burden on real life data. Does the hidden iceberg matter to reach the elimination goals?

85. L'Italia come modello per l'Europa e per il mondo nelle politiche sanitarie per il trattamento dell'epatite cronica da HCV

86. Association of kidney disease measures with risk of renal function worsening in patients with type 1 diabetes

87. Impact of DAAs on liver transplantation: Major effects on the evolution of indications and results. An ELITA study based on the ELTR registry

91. Impact of DAAs on liver transplantation: Major effects on the evolution of indications and results. An ELITA study based on the ELTR registry

92. Dynamic contrast enhanced perfusion CT imaging: A diagnostic biomarker tool for survival prediction of tumour response to antiangiogenetic treatment in patients with advanced HCC lesions

93. Optimising the clinical strategy for autoimmune liver diseases: Principles of value-based medicine

94. Molecular mechanisms driving cholangiocarcinoma invasiveness: an overview

95. The Deleterious Interplay Between Tumor Epithelia and Stroma in Cholangiocarcinoma

96. Pathophysiologic implications of innate immunity and autoinflammation in the biliary epithelium

97. Subcutaneous insulin infusion (CSII) in italy: The third national survey [La terapia insulinica sottocutanea continua (CSII) in Italia. Terza indagine nazionale]

98. Continuous subcutaneous insulin infusion in Italy: Third national survey

99. ELITA consensus statements on the use of DAAs in liver transplant candidates and recipients

Catalog

Books, media, physical & digital resources